A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
Completed
Conditions studied: Pancreatic Cancer
In brief
Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal cells. Investigators at The University of Michigan are conducting a research project, to see if treatment effects on an individual patient's cancer cells can be detected early by new imaging tests in patients with resectable pancreatic cancer undergoing neoadjuvant chemoradiotherapy.
Key facts
- Study ID
- NCT01209962
- Run by
- University of Michigan Rogel Cancer Center
- People needed
- 20
- Starts
- 2008-05-01
- Expected to finish
- 2015-05-26
- Last updated by the study team
- 2017-07-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with histologic or cytologic proof of pancreatic cancer, for whom the treatment plan, at the time of enrollment, is neoadjuvant chemoradiotherapy followed by surgical resection.
- Patients must be >18 years old.
- Patients cannot weight over 300 pounds, the weight limit of the MRI table.
- Patients must have adequate renal function (estimated glomerular filtration rate > 60 mL/min/m2), to minimize the small risk of nephrogenic systemic sclerosis associated with gadolinium injection.
- Patients must sign an informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of UM hospital.
You may not qualify if…
- Patients must have no previous radiation to the abdomen.
- Patients who are pregnant or lactating are excluded.
Where it is running
- University of Michigan Cancer Center — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.